SOSEI HEPTARES - Trademark Details
Status: 653 - Suspension Letter - Mailed
Serial Number
79288175
Word Mark
SOSEI HEPTARES
Status
653 - Suspension Letter - Mailed
Status Date
2021-09-09
Filing Date
2020-04-09
Mark Drawing
4000 - Standard character mark
Typeset
Attorney Name
Law Office Assigned Location Code
N20
Employee Name
ROSEN, BENJAMIN H
Statements
Goods and Services
chemical products and proteins for manufacturing chemical and biological pharmaceutical products; chemical products and proteins for the scientific research of chemical and biological pharmaceutical products; chemical products and proteins for diagnostic use, except medical or veterinary uses, namely, diagnostic preparations for scientific use; proteins and specifically proteins in the nature of G-protein-coupled receptors for manufacturing pharmaceutical products; proteins and specifically proteins in the nature of G-protein-coupled receptors, for the scientific research of pharmaceutical products; chemicals and proteins for chemical and biological drug discovery, lead identification and diagnostics, namely, chemical and biological preparations for use in scientific purposes; proteins and G-protein-coupled receptors for drug discovery purpose, namely, proteins and biological preparations for use in scientific research; chemicals preparations and biologicals preparations for scientific research purposes, being proteins, transmembrane proteins and G proteins, G-protein-coupled receptors, and fragments thereof being sequences of amino acids, for chemical and biological drug discovery, lead identification and diagnostics; proteins, including transmembrane proteins and G-proteins, G-protein-coupled receptors, and fragments thereof being sequences of amino acids, all for use in scientific pharmaceutical research and scientific pharmaceutical research in the nature of drug discovery purposes
Goods and Services
Biological products for medical use in chemical and biological drug discovery, lead identification and diagnostics, namely, diagnostic preparations for medical use and pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; biological products for therapeutic purposes, namely, pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; proteins for medical use in chemical and biological drug discovery, lead identification and diagnostics, namely, diagnostic preparations for medical use and pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; medicines¿, namely, diagnostic preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; cleaning agent for medical use, namely, namely, medical cleansers for skin wounds; biological formulation for medical use in developing chemical and biological pharmaceutical products, namely, pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; biological formulation for medical use in identifying lead chemical and biological products, namely, diagnostic preparations for medical use and pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; biological formulation for medical diagnostic use, namely, diagnostic preparations for medical use; biological formulation for therapeutic use, namely, pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; proteins and G-protein-coupled receptors for medical use in drug discovery; biologicals and small chemical entities, including proteins, G-protein-coupled receptors, transmembrane proteins, G-proteins, antibodies and peptides for therapeutic purposes, namely, diagnostic preparations for medical use; proteins, G-protein-coupled receptors, transmembrane proteins, G-proteins, antibodies and peptides for use in medical diagnostics, namely, diagnostic preparations for medical use and pharmaceutical preparations for the treatment of conditions and diseases of the central nervous system, metabolic system, inflammatory disorders, immune system, cancer, cardiovascular system, reproductive system, respiratory system, ocular system, for use in dermatology, gastrointestinal system, pain relief and neuromuscular system; medical oiled paper; drug delivery agents in the form of edible pharmaceutical wafers for wrapping powdered pharmaceuticals; gauze for dressings; specialized capsules for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; eye patches for medical purposes, ear bandages; menstrual bands being sanitary pads; menstrual tampons; menstrual napkins, namely, menstrual symptom treatment preparations; menstrual underwear, namely, panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; collodion for pharmaceutical purposes; cotton swabs for medical purposes; breast-nursing pads
Goods and Services
Bio-technology, pharmaceutical and scientific testing, research and development; biological research services; research and development services in the pharmaceutical and biopharmaceutical fields;, research and development services in the pharmaceutical and biopharmaceutical fields, namely, in the field of technologies related to proteins and G-protein-coupled receptors; research services in biology and chemistry fields; pharmaceutical research services in chemical and biological drug discovery and development; scientific and pharmaceutical research and development services for identifying lead chemical compounds; scientific analysis and research services in medicinal and synthetic chemistry; research and development services in the creation of libraries or collections of biologicals, chemicals and compounds; pharmaceutical research and development in the nature of research, creation, development and provision of chemical and biological drug targets for non-medical scientific screening purposes; technical diagnostic testing services, namely, scientific and pharmaceutical research and development; scientific research, analysis and examination for identification of compounds through automated screening processes, being scientific and pharmaceutical research and development; research and development services in chemical and biological pharmaceutical development; provision of information, advisory services and consultancy relating to the aforesaid services
Translation of Words in Mark
The English translation of "SOSEI" in the mark is "DO AS YOU WISH".
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
6 - Active
Class Status Date
2020-06-26
Primary Code
001
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-06-26
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-06-26
Primary Code
042
Current Trademark Owners
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Rebecca Liebowitz
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1537344
International Registration Date
2020-04-09
International Publication Date
2020-06-25
International Renewal Date
2030-04-09
Auto Protection Date
2021-12-25
International Status
001 - Request for extension of protection established
International Status Date
2020-06-25
Priority Claimed In
True
Priority Claimed Date
2019-10-29
First Refusal In
True
Trademark Events
Event Date | Event Description |
2020-06-25 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2020-06-26 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2020-06-26 | ASSIGNED TO EXAMINER |
2020-06-29 | NON-FINAL ACTION WRITTEN |
2020-06-30 | APPLICATION FILING RECEIPT MAILED |
2020-06-30 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2020-06-30 | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
2020-07-02 | NON-FINAL ACTION WRITTEN |
2020-07-03 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2020-08-11 | REFUSAL PROCESSED BY MPU |
2020-08-11 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2020-08-30 | REFUSAL PROCESSED BY IB |
2021-02-04 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-02-04 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-02-04 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-03-05 | EXAMINERS AMENDMENT -WRITTEN |
2021-03-05 | EXAMINERS AMENDMENT E-MAILED |
2021-03-05 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2021-03-05 | EXAMINER'S AMENDMENT ENTERED |
2021-03-09 | FINAL REFUSAL WRITTEN |
2021-03-09 | FINAL REFUSAL E-MAILED |
2021-03-09 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2021-09-09 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2021-09-09 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-09-09 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-09-09 | SUSPENSION LETTER WRITTEN |
2021-09-09 | CORRESPONDENCE E-MAILED |
2021-12-01 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
2021-12-01 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2021-12-19 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |